Atlas Trials

Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease

Clinical trial NCT06932874 · RECRUITING

Trial details

NCT number
NCT06932874
Sponsor
China National Center for Cardiovascular Diseases
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Atherosclerotic Heart DiseaseType 2 Diabetes
Start date
2025-03-04
Primary completion
2026-12-31
Enrollment
356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.